medmix AG (SWX:MEDX)
Switzerland · Delayed Price · Currency is CHF 8.84
+0.25 (2.91%)
Jul 31, 2026, 5:30 PM CET
medmix AG Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, medmix AG stock has a consensus rating of "Strong Buy" and an average price target of CHF 15.80. The average 1-year stock price forecast is 78.73% higher than the current stock price, while the lowest is CHF 15.40 (+74.21%) and the highest is CHF 16.00 (+81.00%).
Price Target: CHF 15.80 (+78.73%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Mar 10, 2026.
Analyst Ratings
The average analyst rating for medmix AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Nov '25 | Feb '26 | Mar '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains CHF 18.00 → CHF 16.00 | Buy | Maintains | CHF 18.00 → CHF 16.00 | +81.00% | Mar 10, 2026 |
Financial Forecast
Revenue This Year
443.55M
from 448.00M
Decreased by -0.99%
Revenue Next Year
469.61M
from 443.55M
Increased by 5.88%
EPS This Year
0.51
from 0.78
Decreased by -34.48%
EPS Next Year
0.57
from 0.51
Increased by 12.59%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CHF.